Sakar Healthcare Limited informed that the Small Volume Parenteral (SVP) manufacturing unit of liquid injections and Iyophilised injections is now European Union GMP approved to manufacture and supply products to Europe and other developed countries, as the regulatory body has issued the Certificate of GMP compliance of a Manufacturer against file number 381-10-05/162-03-20 stating the liquid injection and Iyophilised injection unit (SVP) at Sakar complies with the Good Manufacturing Practices requirements referred to in The principles and guidelines of Good Manufacturing Practice laid down in Directive 2003/94/EC. With this approval Sakar is now prepared to export the diverse product portfolio across 30 countries in Europe and other developed countries worldwide. The certification will enable Sakar to reach and cater to the growing needs of patients in the EU markets and provide affordable and innovative medicines in coming years. Sakar can leverage the expertise as a Contract Manufacturing Organisation for multinational companies located in these regions, allowing further consolidation of export globally.